エドガーで原本を確認する
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 6, 2026
_______________________________
EXPONENT, INC.
(Exact name of registrant as specified in its charter)
_______________________________
| Delaware | 0-18655 | 77-0218904 |
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
149 Commonwealth Drive
Menlo Park, California 94025
(Address of Principal Executive Offices) (Zip Code)
(650) 326-9400
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
_______________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.001 per share | EXPO | Nasdaq Global Select Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company,indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Appointment of John D. Pye, Ph.D.
On April 6, 2026, Exponent, Inc.’s (the “Company”) board of directors (the “Board”) appointed Dr. Pye as its President, effective as of May 1, 2026. Dr. Pye, age 55, joined the Company in 1999. He was promoted to Principal Engineer in 2006 and was appointed Corporate Vice President in 2009. Dr. Pye was appointed Group Vice President in January 2014 and was appointed Vice President of Global Offices and Innovation on November 22, 2024. Dr. Pye received his Ph.D. (1999) in Aerospace Engineering from Stanford University, M.S. (1993) in Aerospace Engineering from Stanford University, and B.A.Sc. (1992) in Engineering Science from the University of Toronto, Canada. He is a Registered Professional Mechanical Engineer in the State of California. Prior to joining Exponent, Dr. Pye held a research position in the Aerospace Fluid Mechanics Lab at Stanford University where he was responsible for the renovation and redesign of the Stanford Low-Speed wind tunnel as well as managing the Stanford experimental facilities for the Stanford/NASA Ames Joint Institute for Aeronautics and Astronautics.
Effective upon Dr. Pye’s commencement of services as President, Dr. Pye’s base salary will be $650,000. On April 6, 2026, Dr. Pye received a grant of stock options with respect to 21,000 shares of the Company’s common stock that will vest in four equal parts on an annual basis over a four-year period.
There are no arrangements or understandings between Dr. Pye and any other persons pursuant to which Dr. Pye was named to this position with the Company. Dr. Pye does not have any family relationship with any of the Company’s directors or executive officers or any persons nominated or chosen by the Company to be a director or executive officer. Dr. Pye has no direct or indirect material interest in any transaction or proposed transaction required to be reported under Section 404(a) of Regulation S-K or Item 5.02(c) of Form 8-K.
Appointment of Eric Anderson
On April 6, 2026, the Board appointed Mr. Anderson as its Chief Financial Officer, effective as of May 1, 2026. On May 1, 2026, Mr. Schlenker, the Company’s current Executive Vice President and Chief Financial Officer will cease his role as Chief Financial Officer, but continue in his role as Executive Vice President.
Mr. Anderson, age 51, joined the Company as Controller in 2003, was appointed Vice President in 2013, and has served as Vice President of Finance and Accounting since 2024. Prior to Exponent, Mr. Anderson was a Senior Manager in the Assurance Practice with KPMG, LLP, where he worked for approximately 7 years. Mr. Anderson holds a B.S. in Business Administration from California State University, Chico.
Effective upon Mr. Anderson’s commencement of services as Chief Financial Officer, Mr. Anderson’s base salary will be $525,000. On April 6, 2026, Mr. Anderson received a grant of stock options with respect to 12,600 shares of the Company’s common stock that will vest in four equal parts on an annual basis over a four-year period.
There are no arrangements or understandings between Mr. Anderson and any other persons pursuant to which Mr. Anderson was named to this position with the Company. Mr. Anderson does not have any family relationship with any of the Company’s directors or executive officers or any persons nominated or chosen by the Company to be a director or executive officer. Mr. Anderson has no direct or indirect material interest in any transaction or proposed transaction required to be reported under Section 404(a) of Regulation S-K or Item 5.02(c) of Form 8-K.
Retirement of Paul R. Johnston, Ph.D.
On April 6, 2026, Dr. Johnston informed the Board that he would be retiring from the Board effective as of the Company’s Annual Meeting of Stockholders to be held on June 4, 2026. At such time, Karen Richardson, who currently serves as the Board’s Lead Independent Director, will commence serving as the Chairman of the Board.
| 99.1 | Press release dated April 6, 2026. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Exponent, Inc. | ||
| Date: April 6, 2026 | By: | /s/ Richard L. Schlenker |
| Richard L. Schlenker | ||
| Executive Vice President and Chief Financial Officer | ||
EXHIBIT 99.1
Exponent Elevates John Pye to President and Eric Anderson to CFO Reporting to Catherine Corrigan, CEO; Rich Schlenker to Remain as Executive VP and to Stand for Election to Board of Directors
MENLO PARK, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), a leading engineering and scientific consulting firm, today announced its appointment of John Pye to President and Eric Anderson to Chief Financial Officer, both effective May 1, 2026 and reporting to Catherine Corrigan, Chief Executive Officer; nomination of Richard Schlenker, Executive Vice President and current Chief Financial Officer to stand for election to the Board of Directors; and the appointment of Karen Richardson as Chairman of the Board upon the retirement of Paul Johnston effective as of the Annual Meeting of Stockholders to be held on June 4, 2026.
Dr. Pye joined Exponent in 1999, was promoted to Principal Engineer in 2006, and held roles of increasing responsibility in the firm including Director of the Test and Engineering Center in Phoenix, Director of the Technology Development Practice, Corporate Vice President, and Group Vice President for the Transportation Group. He has led some of the firm’s most technically ambitious and innovative multidisciplinary programs, managed large-scale and category-leading consulting and testing operations, and played a key role in expanding Exponent’s work at the intersection of emerging technology, safety, and transformational challenges. In his current role as Vice President of Global Offices and Innovation, John is spearheading growth through the evolution of Exponent’s innovation agenda, driving investments in advanced capabilities and strengthening the firm’s ability to address increasingly complex client challenges.
“John is a visionary leader with deep technical credibility and a keen ability to see around corners—anticipating how accelerating technological change, evolving risk, and heightened scrutiny of safety and performance will create opportunities for growth,” said Dr. Corrigan. “He has consistently challenged the firm to think bigger, move faster, and innovate more boldly, while staying grounded in the technical rigor and independence that define Exponent. As we evolve our capabilities and empower our people to solve increasingly complex challenges, John’s collaborative leadership style and proven ability to foster a culture of innovation make him exceptionally well suited to lead Exponent into its next stage of growth.”
“Exponent is uniquely situated at the intersection of science, engineering, and real-world impact, and my vision is to build from this position of strength to accelerate the growth of a firm that leads through periods of rapid change,” said Dr. Pye. “By investing in innovation and our people, deepening collaboration across disciplines, and staying relentlessly focused on technical excellence, we will evolve our capabilities to meet our clients’ most complex challenges. I am excited to work with our leadership and our people to shape Exponent’s future growth.”
Eric Anderson joined the firm as Controller in 2003, was appointed Vice President in 2013, and has served as Vice President of Finance and Accounting since 2024. He brings deep financial and operational expertise to the Chief Financial Officer role, along with a deep understanding of Exponent’s business, culture, and diversified portfolio of work. He has extensive experience in financial planning and analysis, regulatory compliance, risk management, and forecasting, and has been instrumental in strengthening Exponent’s financial processes and upholding the firm’s commitment to the highest ethical standards in financial reporting. Richard Schlenker, Exponent’s current Chief Financial Officer and Executive Vice President, effective May 1, 2026, will cease in his role as Chief Financial Officer, but continue in his role as Executive Vice President.
“Eric’s appointment reflects both his exceptional technical capabilities and the high level of trust he has earned across Exponent,” said Dr. Corrigan. “He combines rigorous financial discipline with a deep understanding of our strategy and operations, and he has consistently demonstrated sound judgment, integrity, and a collaborative leadership style. I am confident he will be a strong partner as we continue to execute our long-term growth strategy.”
Dr. Paul Johnston, Chairman of the Board and former CEO, will retire from the Board effective as of the Annual Meeting of Stockholders to be held on June 4, 2026. Karen Richardson, currently the Lead Independent Director, has been appointed to serve as the Chairman of the Board at that time. In addition, the Board has approved the nomination of Richard Schlenker, Executive Vice President and current Chief Financial Officer, to stand for election as a Director.
“Paul’s leadership and vision of excellence have had a profound impact on Exponent over his 45-year tenure with the firm,” said Dr. Corrigan. “On a personal level, Paul has been an incredibly impactful mentor to both John and me and to so many leaders across the firm. I am immensely grateful for his lasting contributions, and I am confident in the continued strength of the Board under Karen’s leadership and with the addition of Rich’s deep financial expertise, sound judgment, and strong enterprise perspective.”
“On behalf of the Board and the entire firm, we thank Paul for his immeasurable contributions to Exponent,” said Ms. Richardson. “I am honored to take on the role of Chairman and look forward to continuing to build on the strong foundation Paul helped establish.”
“I am fully supportive of these leadership appointments and deeply confident in the direction they set for Exponent,” said Dr. Johnston. “John Pye brings exceptional vision, technical depth, and an unwavering commitment to innovation as President, while Eric Anderson provides the financial discipline, judgment, and operational insight essential to sustaining Exponent’s long-term growth. I am equally pleased to see Karen Richardson assume the role of Chairman of the Board; her experience, integrity, and understanding of Exponent’s culture will serve the firm and its stockholders extremely well. Finally, I welcome the nomination of Rich Schlenker to the Board of Directors, where his deep institutional knowledge and strategic perspective will be invaluable. Together, this team reflects Exponent’s strong leadership bench and positions the firm exceptionally well for its next chapter.”
About Exponent
Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.
Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.
Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.
Forward Looking Statements
This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.